EKSOEkso Bionics Holdings, Inc.

$29M

Q4 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$3M-38.3% YoY

Gross Profit

$2M53.2% margin

Operating Income

-$5M-143.6% margin

Net Income

-$5M-148.9% margin

EPS (Diluted)

$-1.57

QoQ Revenue Growth

-25.7%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$758,000

Balance Sheet

Total Assets

$20M

Total Liabilities

$11M

Stockholders' Equity

$9M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$5M	-38.3%
Gross Profit	$2M	$3M	-38.4%
Operating Income	-$5M	-$2M	-102.2%
Net Income	-$5M	-$3M	-36.9%

Geographic Segments

Americas

$1M25%

UNITED STATES

$1M25%

Other Country

$1M18%

EMEA

$939,00016%

Asia Pacific

$721,00012%

FRANCE

$280,0005%

Americas Other

$17,0000%

EKSO Q4 2025 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena